The entrance to the FDA's White Oak campus in Maryland, with the Federal Research Center sign
  • November 21, 2026
  • Anees
  • 0

The White House has withdrawn Dr Heidi Overton’s nomination to lead the Food and Drug Administration, pulling the nomination late on Tuesday on the eve of a Senate committee vote she might well have won.

Key Points

  • Heidi Overton FDA nomination withdrawn — the White House pulled Dr Heidi Overton’s nomination to be FDA commissioner on 17 November, one day before the Senate Health Committee was due to vote on it.
  • A senior administration official said Overton lacked the support on Capitol Hill to be confirmed. But the committee’s chairman, Senator Bill Cassidy, said she had a viable path and the White House abandoned it.
  • Overton, a surgeon and White House domestic policy adviser, helped draft an August executive order to split the combined MMR vaccine into three separate shots.
  • Her nomination became a fault line in the Republican Party over vaccines, the abortion pill and the Make America Healthy Again movement.
  • Senator Roger Marshall is being considered as a replacement. The FDA has been led by acting commissioner Kyle Diamantas since May.
A syringe and vaccine vials (illustrative photo)

The withdrawal was confirmed late on Tuesday and first reported by Axios. Overton had been nominated in August, after leadership turmoil at the FDA, and questioned by the Senate Health Committee at a hearing in September. Then nothing happened for weeks — until the committee finally scheduled its vote for Wednesday morning, and the White House acted the night before.

The official reason was the vote count. According to two people familiar with the decision, the White House concluded on Tuesday night that Overton did not have enough Republican support to advance to the full Senate. She would have needed every Republican on the committee, and the administration decided she could not get it. But Cassidy, the Louisiana Republican who chairs the committee, gave a very different account. He said the White House withdrew her rather than give anti-abortion senators assurances about the abortion pill mifepristone, and that she would have had the votes to advance.

The vaccine order at the centre of the fight

Overton’s troubles began with her role in the administration’s vaccine policy. In August, she helped draft an executive order to split the combined measles, mumps and rubella (MMR) vaccine into three separate shots, and to cut the number of diseases covered by the routine childhood schedule from 18 to 11. At her September hearing, Cassidy pressed her on whether she would stand up to the president on vaccines. She told the committee the measles vaccine is safe and effective — but the order itself had already raised doubts about her candidacy among senators in both parties.

The timing made the fight worse. The United States is in the middle of its worst measles outbreak in roughly 30 years, with more than 5,400 cases counted this year, and on the same Tuesday the nomination was withdrawn, the Pan American Health Organization announced that the country had lost its measles elimination status after 26 years. Physicians and consumer advocates also questioned whether Overton would follow the science on politicised issues such as vaccines and abortion.

The abortion question was the other fault line. The FDA is reviewing the safety of mifepristone, with a decision due by March, and that review could affect the rules that allow the drug to be mailed and dispensed by telehealth. Cassidy’s account is that the White House would not give anti-abortion senators the assurances they wanted — and chose to drop its nominee instead.

What happens next

The FDA now has no nominee, and the search for a replacement is already under way. Senator Roger Marshall of Kansas is being considered for the job, and Health Secretary Robert F. Kennedy Jr. is said to have reached out to him. Whoever is nominated next will face the same questions that sank Overton: vaccines, the abortion pill and the future of the Make America Healthy Again movement.

For background on the measles outbreak behind the vaccine fight, see our report on US Loses Measles Elimination Status After 26 Years as Cases Pass 5,400, and on Merck Cancer Drug Prolongs Survival in Advanced Stomach and Oesophageal Cancers. More in our Health section.

Sources: Drug Topics, “White House Withdraws Heidi Overton’s Nomination as FDA Commissioner” (https://www.drugtopics.com/view/white-house-withdraws-heidi-overton-s-nomination-as-fda-commissioner); NPR, via Public Radio East, “White House withdraws nominee for FDA commissioner” (https://www.publicradioeast.org/2026-11-18/white-house-withdraws-nominee-for-fda-commissioner)

Leave a Reply

Your email address will not be published. Required fields are marked *